Dual anti-platelet therapy in secondary stroke prevention

Author: Springer Healthcare IME

Professor Marc Fisher and Springer Healthcare IME invite you to listen to these three podcast discussions with experts in this therapy area. The podcasts focus on the clinical implications of recently published results from clinical trials involving the use of dual-anti-platelet therapy for secondary stroke prevention.
Be a guest on this podcast

Language: en

Genres: Health & Fitness, Life Sciences, Medicine, Science

Contact email: Get it

Feed URL: Get it

iTunes ID: Get it

Get all podcast data

Listen Now...

Discussion of the CHANCE and PRINCE clinical trials (with Marc Fisher and Liping Liu)
Tuesday, 2 March, 2021

Professors Marc Fisher and Liping Liu discuss the CHANCE and PRINCE clinical trials focusing on their backgrounds and key results, and commenting on their clinical implications. This programme is made possible thanks to an independent educational grant from AstraZeneca. Find more information at https://ime.springerhealthcare.com/programs/emerging-dual-anti-platelet-therapy-strategies-for-neurologists-in-secondary-stroke-prevention/